Multibagger Selection: Perplexity's picks
Perplexity picked MAZE, EVER, PGY, PENG, SOUN with a twelve-month thesis, measured against SPY at each checkpoint.
| Experiment | Multibagger Selection |
|---|---|
| Model | Perplexity |
| Prompt version | multibagger-selection-v1 |
| Asked | |
| Horizon | 12-month |
| Benchmark | SPY |
| Status | Being measured |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | MAZE | — | 45% | — | — |
| 2 | EVER | — | 55% | — | — |
| 3 | PGY | — | 50% | — | — |
| 4 | PENG | — | 45% | — | — |
| 5 | SOUN | — | 35% | — | — |
Checkpoints
| Checkpoint | Portfolio return | Return vs SPY | Best peak multiple | Picks reaching 2x |
|---|---|---|---|---|
| 1 week | -4.23% | -3.04% | 1.10x | 0 |
The model's market view
Small- and mid-cap conditions are selective rather than broadly easy: lower rates and AI-related capital spending support growth names, but elevated yields and valuation discipline penalize unprofitable or highly leveraged companies. The strongest multibagger candidates therefore combine a dated, verifiable catalyst with an operating inflection, adequate liquidity, and enough valuation headroom that success is not already fully priced.
Why each pick
MAZE
Maze Therapeutics is a clinical-stage biotechnology company with a market capitalization near USD 1.51 billion and a late-stage pipeline whose value depends chiefly on clinical execution. The stock closed at USD 27.11 on 2026-10-09, while stockanalysis.com reported a USD 61.50 consensus 12-month target from 13 analysts, indicating substantial perceived upside if pipeline data and regulatory progress validate the platform. This is a higher-variance discovery candidate: the operating inflection is clinical rather than commercial, and a 3x outcome would require unusually strong data and a durable re-rating.
EVER
EverQuote is an insurance marketplace with a market capitalization of approximately USD 698 million to USD 713 million and a recent price of USD 19.80. Zacks reported that revenue rose approximately 41% year over year in the first nine months of 2026, while the 2026 consensus EPS estimate rose from USD 1.55 to USD 1.74, implying expected earnings growth of 19.1% on projected revenue growth of 14.4%. The combination of rapid recent growth, profitability, modest market capitalization, and a low reported P/E of 6.45 gives the thesis more fundamental support than a typical speculative growth name.
PGY
Pagaya Technologies is an AI-driven lending-network and financial-infrastructure company with a USD 1.52 billion market capitalization and a recent closing price of USD 18.22. Simply Wall St reported trailing-twelve-month revenue of USD 1.39 billion and earnings of USD 122.54 million, while analyst coverage remains active, with a reported average target of USD 38.00 from 10 analysts. The thesis rests on continued network-volume growth, improving profitability, and re-rating as the market gains confidence in the durability of its asset-management and network revenue.
PENG
Penguin Solutions provides AI infrastructure, high-performance computing systems, memory solutions, and edge technology. Its market capitalization was USD 3.91 billion and its delayed price was USD 76.28 as of 2026-10-09, according to Morningstar. The company benefits from AI data-center and edge-computing demand, but its larger capitalization and premium valuation mean a 3x outcome requires exceptional execution rather than merely continued industry growth.
SOUN
SoundHound AI develops voice-enabled and AI-powered interfaces for automotive, enterprise, restaurant, and healthcare markets. Yahoo Finance reporting cited accelerating adoption across these verticals as supporting double- and triple-digit revenue growth and improved customer diversification. It is included as the fifth candidate because of its visible commercialization ramp, but its market capitalization is near the upper limit of the required range and its valuation leaves limited margin for disappointment; the latest price could not be verified in this session, so reference_price is omitted.
Other models on the same run
| Model | Picks |
|---|---|
| Gemini 1.5 Pro | LUNR, SOUN, ENVX, ACHR, SMR |
| Muse Spark 1.1 | EOSE, LUNR, SOUN, TMC, LAC |
| Grok 4.5 | INOD, NRIX, IVA, AAPG, BBAI |
| DeepSeek | INOD, AEHR, ASYS, BBAI, HTFL |
| GPT-6 | TSSI, INOD, SEDG, AMPX, LUNR |
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.